Short versus prolonged antibiotic treatment for complicated urinary tract infection after kidney transplantation

被引:8
作者
Avni-Nachman, Shiri [1 ]
Yahav, Dafna [2 ,3 ]
Nesher, Eviatar [3 ,4 ]
Rozen-Zvi, Benaya [3 ,5 ]
Rahamimov, Ruth [3 ,4 ,5 ]
Mor, Eytan [3 ,6 ]
Ben-Zvi, Haim [3 ,7 ]
Milo, Yaniv [3 ]
Atamna, Alaa [2 ]
Green, Hefziba [1 ,3 ,5 ]
机构
[1] Rabin Med Ctr, Dept Med B, Beilinson Campus,Jabutisky St 39, IL-4941492 Petah Tiqwa, Israel
[2] Rabin Med Ctr, Infect Dis Unit, Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[4] Rabin Med Ctr, Transplant Dept, Petah Tiqwa, Israel
[5] Rabin Med Ctr, Nephrol & Hypertens, Petah Tiqwa, Israel
[6] Sheba Med Ctr, Transplant Ctr, Dept Surg & Transplantat, Ramat Gan, Israel
[7] Rabin Med Ctr, Beilinson Hosp, Microbiol Lab, Petah Tiqwa, Israel
关键词
antibiotic stewardship; kidney transplantation; mortality; readmission; urinary tract infection; RENAL-TRANSPLANTATION; ACUTE PYELONEPHRITIS; RISK-FACTORS; EPIDEMIOLOGY; RECIPIENTS; DURATION; THERAPY; BACTEREMIA;
D O I
10.1111/tri.14144
中图分类号
R61 [外科手术学];
学科分类号
摘要
There is no consensus regarding the optimal duration of antibiotic therapy for urinary tract infection (UTI) following kidney transplantation (KT). We performed a retrospective study comparing short (6-10 days) versus prolonged (11-21 days) antibiotic therapy for complicated UTI among KT recipients. Univariate and inverse probability treatment weighted (IPTW) adjusted multivariate analysis for composite primary outcome of all-cause mortality or readmissions within 30 days and relapsed UTI 180 days were performed. Overall, 214 KT recipients with complicated UTI were included; 115 short-course treatment (median 8, interquartile range [IQR] 6-9 days), 99 prolonged course (median 14, IQR 12-21 days). The composite outcome occurred in 33 (28.6%) in the short-course group and 30 (30%) in the prolonged-course group; relapsed UTI occurred in 19 (16.5%) vs. 21 (21%), respectively. Duration of antibiotic treatment was not associated with any of these outcomes. The only risk factor for mortality/readmissions in multivariate analysis was deceased donor. No differences between groups were demonstrated for length of hospital stay, rates of bacteraemia, resistance development, and serum creatinine at 30 and 90 days. In conclusion, we found no difference in clinical outcomes between KT recipients treated for complicated UTI with short-course antibiotic (6-10 days) versus longer course (11-21 days).
引用
收藏
页码:2686 / 2695
页数:10
相关论文
共 30 条
  • [1] Late urinary tract infection after renal transplantation in the United States
    Abbott, KC
    Swanson, SJ
    Richter, ER
    Bohen, EM
    Agodoa, LY
    Peters, TG
    Barbour, G
    Lipnick, R
    Cruess, DF
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (02) : 353 - 362
  • [2] Hospitalizations for bacterial septicemia after renal transplantation in the United States
    Abbott, KC
    Oliver, JD
    Hypolite, I
    Lepler, LL
    Kirk, AD
    Ko, CW
    Hawkes, CA
    Jones, CA
    Agodoa, LY
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (02) : 120 - 127
  • [3] Urinary tract infections in renal transplant recipients
    Alangaden G.J.
    [J]. Current Infectious Disease Reports, 2007, 9 (6) : 475 - 479
  • [4] Infectious complications after kidney transplantation: current epidemiology and associated risk factors
    Alangaden, George J.
    Thyagarajan, Rama
    Gruber, Scott A.
    Morawski, Katherina
    Garnick, James
    El-Amm, Jose M.
    West, Miguel S.
    Sillix, Dale H.
    Chandrasekar, Pranatharthi H.
    Haririan, Abdolreza
    [J]. CLINICAL TRANSPLANTATION, 2006, 20 (04) : 401 - 409
  • [5] Early and recurrent hospitalization after kidney transplantation: Analysis of a contemporary canadian cohort of kidney transplant recipients
    Bergman, Joel
    Tennankore, Karthik
    Vinson, Amanda
    [J]. CLINICAL TRANSPLANTATION, 2020, 34 (08)
  • [6] Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae-Related Urinary Tract Infection in Kidney Transplant Recipients: Risk Factors, Treatment, and Long-Term Outcome
    Brakemeier, S.
    Taxeidi, S. I.
    Zukunft, B.
    Schmidt, D.
    Gaedeke, J.
    Duerr, M.
    Hansen, S.
    Budde, K.
    [J]. TRANSPLANTATION PROCEEDINGS, 2017, 49 (08) : 1757 - 1765
  • [7] Multidrug-resistant bacteria in solid organ transplant recipients
    Cervera, C.
    van Delden, C.
    Gavalda, J.
    Welte, T.
    Akova, M.
    Carratala, J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 49 - 73
  • [8] Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort
    Chotiprasitsakul, Darunee
    Han, Jennifer H.
    Cosgrove, Sara E.
    Harris, Anthony D.
    Lautenbach, Ebbing
    Conley, Anna T.
    Tolomeo, Pam
    Wise, Jacqueleen
    Tamma, Pranita D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (02) : 172 - 177
  • [9] Clostridium difficile Infections in Solid Organ Transplantation
    Dubberke, E. R.
    Burdette, S. D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 42 - 49
  • [10] Foreword
    Eckardt, Kai-Uwe
    Kasiske, Bertram L.
    [J]. KIDNEY INTERNATIONAL SUPPLEMENTS, 2012, 2 (01) : 7 - 7